Galmed Pharmaceuticals
Sector: Healthcare & Life Sciences
About Galmed Pharmaceuticals
Galmed Pharmaceuticals About us People Pipeline News Investors Contact and Careers ARMOR Phase 3 Study Leveraging Science for Lifetime Medicine From a one-man discovery to a passionate global drug development team working on the next generation of metabolic and inflammatory therapeutics About Us From Bench to Bedside We leverage science to deliver effective, safe, and tolerable lifetime medicine
Products
Aramchol
For the treatment of liver disease. Aramchol for the treatment of combination therapy for NASH. Also seeking to develop Aramchol for certain oncological indications outside of NASH and fibrosis. In addition, as part of their growth strategy, they are actively pursuing opportunities to expand and diversify our product pipeline specifically targeting cardiometabolic indications and other innovative product candidates that align with our core expertise in drug development.